Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 968 of 6351
-
Could extra radiation spots stop prostate Cancer's return?
Disease control Recruiting nowA randomized phase III trial to study the effect of adding lymph node irradiation in patients with poor prostate-specific antigen (PSA) response during salvage radiotherapy for biochemical recurrence (0.15 ≤ PSA \<0.70 ng/ml) after prostatectomy.
Sponsor: Lund University Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:04 UTC
-
New heart valve replacement could offer hope for patients with severe tricuspid leak
Disease control OngoingPivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Blood test guides new attack on lung cancer return
Disease control PausedIn this study circulating tumor DNA (ctDNA) blood testing is used to detect the residual blood cancer. If residual cancer using this blood test is detected there may be at higher risk of having the cancer return. The study is going to test whether or not the number of circulating…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for Hard-to-Treat breast cancer: Triple-Drug combo shows promise
Disease control OngoingThe goal of this study is to evaluate the efficacy and safety of tucatinib in combination with trastuzumab and capecitabine in participants with unresectable locally advanced or metastatic HER2+ breast cancer who have had prior treatment with taxane anti-cancer agent, trastuzumab…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for blood cancer patients: experimental drug takes on standard therapy
Disease control OngoingThis is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib (LOXO-305) to other drugs that work in a similar way that have already been approved by the United States Food and Drug Administration (US …
Phase 3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug cocktail aims to boost myeloma treatment before and after transplant
Disease control OngoingThis is a multicenter, open label clinical trial evaluating the safety of the combination of belantamab mafodotin + the combination treatment VRd (bortezomib, lenalidomide, dexamethasone) in newly diagnosed (ND) transplant eligible multiple myeloma (MM) patients. Eligible patien…
Phase 2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Brain cancer trial tests Chemo-First strategy to spare patients from radiation side effects
Disease control Recruiting nowOligodendrogliomas in the novel edition of the Central Nervous System (CNS) World Health Organization (WHO) classification are now molecularly defined by isocitrate dehydrogenase (IDH)1 or IDH2 mutations and 1p/19q co-deletion. The prognosis of these molecularly defined tumors is…
Phase 3 • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug shows promise for painful skin condition
Disease control CompletedThis study is open to adults with a chronic inflammatory skin disease called hidradenitis suppurativa. The purpose of this study is to find out whether a medicine called spesolimab helps people with moderate to severe hidradenitis suppurativa. Participants are put into 2 groups …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for kids with Crohn's: drug aims to tame gut inflammation
Disease control CompletedThe purpose of this study is to evaluate the efficacy of ustekinumab dosing in inducing clinical remission (Global) and in maintaining clinical remission (US); to evaluate the safety profile and ustekinumab exposure (pharmacokinetics \[PK\]) in pediatric participants with moderat…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New pill shows promise against tough blood cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of nemtabrutinib (formerly ARQ 531) in participants with hematologic malignancies of chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), mant…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Heart valve showdown: which TAVR device wins for small aortas?
Disease control OngoingThe purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic severe native aortic stenosis. A…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cell therapy targets tough childhood leukemia
Disease control Stopped earlyPhase 1 open-label study to evaluate the safety of intravenously administered, lentivirally transduced T cells expressing anti-CD123 chimeric antigen receptors expressing tandem TCRζ and 4-1BB (TCRζ /4-1BB) costimulatory domains in pediatric subjects with relapsed/refractory Acut…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Chikungunya vaccine shows promise for Long-Term protection
Vaccine OngoingIn this open-label Phase 3b, single arm trial, persistence of antibodies and long term safety will be evaluated in up to 375 participants rolled over from trial VLA1553-301 (NCT number: NCT04546724).
Phase 3 • Sponsor: Valneva Austria GmbH • Aim: Vaccine
Last updated Jul 11, 2026 00:00 UTC
-
New combo therapy aims to stop endometrial cancer return
Disease control Recruiting nowThis study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial cancer who have recently undergone surgery.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a 7-Day steroid course tame Post-Concussion headaches?
Symptom relief Recruiting nowThis novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who und…
Sponsor: Northwell Health • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Diabetes drug semaglutide tested as potential treatment for fatty liver disease NASH
Disease control OngoingSemaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine - which treatment participants get is decided …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Gene test could tailor chemo for pancreatic cancer patients
Disease control Recruiting nowThis is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New heart attack procedures aim to save more lives and prevent repeat attacks
Disease control Recruiting nowThe purpose of is study is to investigate whether ischemic postconditioning (iPOST) and intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PC…
Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for kids with rare blood cancer: targeted drug trial launches
Disease control Recruiting nowProspective, interventional, open, randomized, single-center, non-commercial clinical trial to optimize treatment and dosage of vemurafenib in juvenile patients with histiocytosis resistant to conventional therapy and in whom the BRAF gene mutation has been found.
Phase 2 • Sponsor: Anna Raciborska • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill could help men with erectile dysfunction achieve and maintain erections
Disease control CompletedThis is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of Tunodafil Hydrochloride Tablets in men with erectile dysfunction.
Phase 3 • Sponsor: Yangtze River Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC